Seif El‐Jack

Primary Endpoint Results of the EVOLVE Trial

Ian T. Meredith, Stefan Verheye, Christophe Dubois et al. · Journal of the American College of Cardiology · 2012 · 203 citations

Medicine, Biostatistics, Outcomes Research +4

The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response

Patrick Gladding, Mark Webster, Irene Zeng et al. · JACC: Cardiovascular Interventions · 2008 · 125 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +11

The Antiplatelet Effect of Higher Loading and Maintenance Dose Regimens of Clopidogrel

Patrick Gladding, Mark Webster, Irene Zeng et al. · JACC: Cardiovascular Interventions · 2008 · 57 citations

Medicine, Pharmacology, Pharmacotherapy +14

Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Ian T. Meredith, Stefan Verheye, Christophe Dubois et al. · EuroIntervention · 2018 · 57 citations

Medicine, Cardiology, Pharmacology +13

PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses

Ian T. Meredith, Robert Whitbourn, Douglas Scott et al. · EuroIntervention · 2011 · 49 citations

Medicine, Cardiology, Surgery +17